Sumitomo Pharma Balance Sheet Health
Financial Health criteria checks 1/6
Sumitomo Pharma has a total shareholder equity of ¥156.1B and total debt of ¥418.9B, which brings its debt-to-equity ratio to 268.3%. Its total assets and total liabilities are ¥907.5B and ¥751.4B respectively.
Key information
268.3%
Debt to equity ratio
JP¥418.88b
Debt
Interest coverage ratio | n/a |
Cash | JP¥29.05b |
Equity | JP¥156.14b |
Total liabilities | JP¥751.37b |
Total assets | JP¥907.51b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4506's short term assets (¥269.6B) do not cover its short term liabilities (¥515.5B).
Long Term Liabilities: 4506's short term assets (¥269.6B) exceed its long term liabilities (¥235.9B).
Debt to Equity History and Analysis
Debt Level: 4506's net debt to equity ratio (249.7%) is considered high.
Reducing Debt: 4506's debt to equity ratio has increased from 6.2% to 268.3% over the past 5 years.
Debt Coverage: 4506's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 4506's interest payments on its debt are well covered by EBIT.